These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 18852530)
21. Association of Angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia. Choi H; Kang JY; Yoon HS; Han SS; Whang CS; Moon IG; Shin HH; Park JB J Korean Med Sci; 2004 Apr; 19(2):253-7. PubMed ID: 15082899 [TBL] [Abstract][Full Text] [Related]
22. Maternal serum and amniotic fluid inhibin A levels in women who subsequently develop severe preeclampsia. Kim SY; Ryu HM; Yang JH; Kim MY; Ahn HK; Shin JS; Choi JS; Park SY; Kim JM; Lee BY; Kim DJ J Korean Med Sci; 2006 Jun; 21(3):452-6. PubMed ID: 16778388 [TBL] [Abstract][Full Text] [Related]
23. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy. Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293 [TBL] [Abstract][Full Text] [Related]
24. Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia. Molvarec A; Vér A; Fekete A; Rosta K; Derzbach L; Derzsy Z; Karádi I; Rigó J Hypertens Res; 2007 Mar; 30(3):205-11. PubMed ID: 17510501 [TBL] [Abstract][Full Text] [Related]
25. Endothelial nitric oxide synthase gene polymorphisms in preeclampsia with or without eclampsia in a Turkish population. Ozturk E; Balat O; Pehlivan S; Ugur MG; Ozcan C; Sever T; Kul S J Obstet Gynaecol Res; 2011 Dec; 37(12):1778-83. PubMed ID: 21793998 [TBL] [Abstract][Full Text] [Related]
26. Inhibin A levels and severity of preeclampsia. Phupong V; Paiwattananupant K; Honsawek S Arch Gynecol Obstet; 2009 Aug; 280(2):183-6. PubMed ID: 19107499 [TBL] [Abstract][Full Text] [Related]
27. Polymorphism in the tumor necrosis factor-alpha gene in women with preeclampsia. Heiskanen J; Romppanen EL; Hiltunen M; Iivonen S; Mannermaa A; Punnonen K; Heinonen S J Assist Reprod Genet; 2002 May; 19(5):220-3. PubMed ID: 12099552 [TBL] [Abstract][Full Text] [Related]
28. Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin alpha knockout mice. Burns KH; Agno JE; Sicinski P; Matzuk MM Mol Endocrinol; 2003 Oct; 17(10):2053-69. PubMed ID: 12855747 [TBL] [Abstract][Full Text] [Related]
29. Inhibin-A and superimposed preeclampsia in women with chronic hypertension. Zeeman GG; Alexander JM; McIntire DD; Byrd W; Leveno KJ Obstet Gynecol; 2003 Feb; 101(2):232-6. PubMed ID: 12576244 [TBL] [Abstract][Full Text] [Related]
30. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Silver HM; Lambert-Messerlian GM; Star JA; Hogan J; Canick JA Am J Obstet Gynecol; 1999 May; 180(5):1131-7. PubMed ID: 10329867 [TBL] [Abstract][Full Text] [Related]
31. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels. Livingston JC; Park V; Barton JR; Elfering S; Haddad B; Mabie WC; Quasney M; Sibai BM Am J Obstet Gynecol; 2001 May; 184(6):1273-7. PubMed ID: 11349201 [TBL] [Abstract][Full Text] [Related]
32. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. Farina A; Sekizawa A; Purwosunu Y; Rizzo N; Banzola I; Concu M; Morano D; Giommi F; Bevini M; Mabrook M; Carinci P; Okai T Prenat Diagn; 2006 Dec; 26(12):1115-20. PubMed ID: 16952198 [TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women. Shim JY; Jun JK; Jung BK; Kim SH; Won HS; Lee PR; Kim A Am J Obstet Gynecol; 2007 Sep; 197(3):271.e1-4. PubMed ID: 17826416 [TBL] [Abstract][Full Text] [Related]
34. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases. Petraglia F; Luisi S; Benedetto C; Zonca M; Florio P; Casarosa E; Volpe A; Bernasconi S; Genazzani AR J Clin Endocrinol Metab; 1997 Sep; 82(9):2991-5. PubMed ID: 9284732 [TBL] [Abstract][Full Text] [Related]
35. Inhibin α gene promoter polymorphisms in Korean women with idiopathic premature ovarian failure. Yoon SH; Choi YM; Hong MA; Kim JJ; Im HJ; Lee GH; Kang BM; Moon SY Hum Reprod; 2012 Jun; 27(6):1870-3. PubMed ID: 22473390 [TBL] [Abstract][Full Text] [Related]
36. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia. Yu J; Shixia CZ; Wu Y; Duan T Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451 [TBL] [Abstract][Full Text] [Related]
37. Investigation of endothelin-1 type A receptor gene polymorphism (-231 G > A) in preeclampsia susceptibility. Lisi V; Paternoster DM; Stecca A; Micciché F; Fantinato S; Leon A; Damante G; Fabbro D; Clementi M J Matern Fetal Neonatal Med; 2007 Feb; 20(2):145-9. PubMed ID: 17437213 [TBL] [Abstract][Full Text] [Related]
38. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels. Florio P; Ciarmela P; Luisi S; Palumbo MA; Lambert-Messerlian G; Severi FM; Petraglia F Gynecol Endocrinol; 2002 Oct; 16(5):365-72. PubMed ID: 12587530 [TBL] [Abstract][Full Text] [Related]
39. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia. Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935 [TBL] [Abstract][Full Text] [Related]